发帖
雷达卡
【来源】： Frost & Sullivan
【文件格式】： pdf 【页数】： 74
【简介及主要行业信息】： In 2011, the U.S. contract manufacturing outsourcing (CMO) market generated $10,735.3 million in revenue. The forecast shows growth of 7.0 percent to 9.0 percent through 2016.
oThe sterile segment is expected to be the primary driver for the growth in the CMO market during the forecast period. •The U.S. CMO market for solids was $4,838.6 million in 2011. The market is expected to grow 3.0 percent to 5.0 percent through 2016.
oGenerics likely will be a key growth driver for this segment; however, growth is expected to be modest due to the shift in focus of big pharma from small molecules to biologics. •The U.S. CMO market for sterile manufacturing was $4,162.1 million in 2011. The market is expected to grow 11.0 percent to 13.0 percent through 2016. oThe sterile market is expected to grow because of increasing pharmaceutical and biotechnological focus on complex disease areas, trends in disease control, growth in emerging markets, the pharmaceutical patent cliff (wherein many popular drugs go off patent), and reformulation of existing products.
oThe cytotoxic sector of the sterile parenteral segment shows the fastest growth. Both cancer research and the development of new cancer treatments are driving growth in this area.
Analysis of the Contract Manufacturing Outsourcing Market.rar
(3.96 MB, 需要: 300 个论坛币)
本附件包括：- Analysis of the Contract Manufacturing Outsourcing Market.pdf
京公网安备 11010802022788号
